Edition:
United Kingdom

Dawnrays Pharmaceutical Holdings Ltd (2348.HK)

2348.HK on Hong Kong Stock

4.58HKD
7:20am BST
Change (% chg)

HK$0.08 (+1.78%)
Prev Close
HK$4.50
Open
HK$4.51
Day's High
HK$4.58
Day's Low
HK$4.50
Volume
561,612
Avg. Vol
414,100
52-wk High
HK$5.50
52-wk Low
HK$3.93

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 391.43 0.181
Jun '17 491.06 0.186
FY 2016 Dec '16 405.90 0.168
Jun '16 418.45 0.164
 
*Note: Units in Millions ofRenminbi
**Note: Units in Renminbi

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 9.78 28.66 32.90
P/E High - Last 5 Yrs. 20.17 41.40 47.21
P/E Low - Last 5 Yrs. 9.68 23.48 24.78
Beta 0.61 0.80 0.79
Price to Sales (TTM) 3.23 3.42 8.29
Price to Book (MRQ) 1.58 3.60 4.33
Price to Tangible Book (MRQ) 1.61 4.46 5.85
Price to Cash Flow (TTM) 8.24 19.59 21.98
% Owned Institutions -- 1.27 2.41

Dividends

  Company industry sector
Dividend Yield 3.39 1.78 1.65
Dividend Yield - 5 Year Avg -- 0.78 0.80
Dividend 5 Year Growth Rate 17.28 2.67 4.07
Payout Ratio(TTM) 33.13 16.62 17.46

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -3.57 3.79 4.91
Sales (TTM) vs TTM 1 Yr. Ago 7.05 10.43 12.76
Sales - 5 Yr. Growth Rate 0.60 7.39 8.10
EPS (MRQ) vs Qtr. 1 Yr. Ago 8.31 39.00 35.43
EPS (TTM) vs TTM 1 Yr. Ago 10.94 -- --
EPS - 5 Yr. Growth Rate 20.78 7.03 8.55
Capital Spending - 5 Yr. Growth Rate -31.96 8.06 8.61

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 4.39 2.55 2.53
Current Ratio (MRQ) 4.77 3.62 3.60
LT Debt to Equity (MRQ) 0.00 10.57 12.91
Total Debt to Equity (MRQ) 0.00 13.08 15.97
Interest Coverage (TTM) -- 39.94 34.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 63.63 55.35 54.97
Gross Margin - 5 Yr. Avg. 57.07 52.67 52.78
EBITD Margin (TTM) 45.46 -- --
EBITD - 5 Yr. Avg 38.72 18.49 15.93
Operating Margin (TTM) 42.20 14.61 0.12
Operating Margin - 5 Yr. Avg. 35.05 14.23 11.20
Pre-Tax Margin (TTM) 41.44 14.89 2.20
Pre-Tax Margin - 5 Yr. Avg. 34.71 14.51 11.41
Net Profit Margin (TTM) 33.20 11.29 -1.22
Net Profit Margin - 5 Yr. Avg. 27.77 10.80 7.70
Effective Tax Rate (TTM) 19.89 22.50 31.30
Effective Tax Rate - 5 Yr. Avg. 19.99 23.91 24.62

Efficiency

  Company industry sector
Revenue/Employee (TTM) 1,259,124 841,727,147 731,572,994
Net Income/Employee (TTM) 418,020 97,990,015 85,104,893
Receivable Turnover (TTM) 5.97 5.60 5.75
Inventory Turnover (TTM) 2.61 2.52 3.58
Asset Turnover (TTM) 0.43 0.88 0.86

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 14.41 10.56 10.07
Return on Assets - 5 Yr. Avg. 13.58 11.70 11.12
Return on Investment (TTM) 16.52 13.20 12.74
Return on Investment - 5 Yr. Avg. 17.29 15.12 14.40
Return on Equity (TTM) 17.02 14.95 14.64
Return on Equity - 5 Yr. Avg. 17.81 16.37 15.76
  1 Year 3 Year 5 Year
Sales % 7.05 4.03 0.60
EPS (TTM) % 10.95 13.10 20.78
Dividend % 7.32 12.38 17.28
Note: Units in Millions of US Dollars

Performance for Dawnrays Pharmaceutical Holdings Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 17.92%
# of Holders: 38
Total Shares Held: 142,157,661
3 Mo. Net Change: 3,125,883
# New Positions: 1
# Closed Positions: 2
# Increased Positions: 10
# Reduced Positions: 5
# Net Buyers: 5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.